Gemcitabine activates the AMPK/mTOR pathway, raising the expression of AMPK and reducing that of mTOR, leading to cell autophagy, which causes tumour cells to stop growing and undergo apoptosis [38]. This evidence concerns the gene MTOR and neoplasm.